| Protective Effects of Hydrogen Saline on Diabetic Retinopathy in a Streptozotocin-Induced Diabetic Rat Model. | |
| | |
MedLine Citation:
|
PMID: 21790325 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Abstract Purpose: Diabetic retinopathy is the leading cause of blindness in the working population of the developed countries and also a significant cause of blindness in the elderly. This study aimed at examining the protective effect of H(2) saline on diabetic retinopathy in a streptozotocin-induced diabetic rat model. Methods: Sprague-Dawley male rats were divided into 3 groups as follows: (1) nondiabetic control group (non-DM control); (2) diabetic control group (DM control); and (3) diabetic rats receiving H(2) saline therapy (DM H(2) saline). Rats in DM H(2) saline group were intraperitoneally injected with H(2) saturated saline (5 mL/kg) every day for 4 weeks. Retinal vascular permeability was assessed by measuring Evans blue leakage into the retina. Retinal apoptosis was evaluated by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining and measuring caspase-3 activity. Retinal thickness was observed by hematoxylin and eosin staining. Results: Our results showed that H(2) saline treatment could depress the caspase activity, reduce the retinal apoptosis, and vascular permeability. The H(2) saline could also prominently attenuate the retinal parenchyma thickening that resulted from diabetic retinopathy. Conclusions: Our preliminary studies indicated that H(2) saline may have potentials in the clinical treatment of diabetic retinopathy. |
| | |
Authors:
|
Xiang Xiao; Jiping Cai; Jiajun Xu; Ruobing Wang; Jianmei Cai; Yun Liu; Weigang Xu; Xuejun Sun; Runping Li |
Related Documents
:
|
10884285 - Increased uptake of alpha-hydroxy aldehyde-modified low density lipoprotein by macropha... 11330505 - Intact insulin, insulin propeptides, and intima-media thickness in the femoral artery i... 8427865 - Lipoprotein profile characterization of the kka(y) mouse, a rodent model of type ii dia... 9790515 - The level of autoantibodies against oxidized ldl is not associated with the presence of... 2537645 - Na/h and li/na exchange in red blood cells of normotensive and hypertensive patients wi... 12832295 - Left ventricular systolic and diastolic function in normotensive type 1 diabetic patien... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-7-26 |
Journal Detail:
|
Title: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics Volume: - ISSN: 1557-7732 ISO Abbreviation: - Publication Date: 2011 Jul |
Date Detail:
|
Created Date: 2011-7-27 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9511091 Medline TA: J Ocul Pharmacol Ther Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
1 Department of Scientific Research, Changzheng Hospital, Second Military Medical University , Shanghai, P.R. China . |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Analysis of Carbonaceous Biomarkers with the Mars Organic Analyzer Microchip Capillary Electrophores...
Next Document: Long-Term Outcomes of Prostaglandin Analog Versus Timolol Maleate in Ocular Hypertensive or Primary ...